Filing Flows › OptimizeRx (OPRX) › Q2 2025
OptimizeRx (OPRX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 8, 2025
OptimizeRx (OPRX) reported revenue of $29.2M for the second quarter 2025 (Q2 2025), +55% from a year earlier and +33% from the quarter before. Operating margin was 11.0%, net earnings $1.5M (5.2% of revenue).
OptimizeRx, Q2 2025: revenue $29.2M (+55% year over year), operating margin 11.0%, net earnings $1.5M, operating cash flow $4.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.2M | +33% | +55% |
| Gross profit | $18.6M | +40% | +59% |
| Operating profit | $3.2M | — | — |
| Net earnings | $1.5M | — | — |
| Operating cash flow | $4.6M | +18% | +483% |
| Free cash flow | $4.6M | +19% | +518% |
What changed
Revenue was $29.2M in Q2 2025, up 55% year over year and up 33% from the previous quarter.
Gross margin was 63.8%, up 1.6 points from a year earlier. Operating profit was $3.2M, a 11.0% margin (up 30.9 points year over year). Operating expenses fell 0% while revenue rose 55%. Net earnings were $1.5M. The effective tax rate was 10.6%.
Operating cash flow was $4.6M (up 483% year over year), 298% of net earnings. Non-cash charges added back $1.1M of depreciation and amortization and $1.5M of share-based compensation. Working capital and other items added $467K. Capital expenditures of $10K left free cash flow of $4.6M.
Questions
What was OptimizeRx's revenue in the second quarter 2025?
OptimizeRx (OPRX) reported revenue of $29.2M for the second quarter 2025 (Q2 2025), +55% from a year earlier and +33% from the quarter before.
Was OptimizeRx profitable in the second quarter 2025?
Operating profit was $3.2M (11.0% of revenue) and net earnings $1.5M.
Source: OptimizeRx 10-Q on SEC EDGAR.